ALKBH5 knockout in tumor cells enhanced the efficacy of immunotherapy, and ALKBH5 could regulate target gene expression and splicing, resulting in changes in metabolite contents and the accumulation of MDSCs (75). Here, ALKBH5 is linked to neoplasm.